» Articles » PMID: 30157906

Relationship Between Epithelial-to-mesenchymal Transition and the Inflammatory Microenvironment of Hepatocellular Carcinoma

Overview
Publisher Biomed Central
Specialty Oncology
Date 2018 Aug 31
PMID 30157906
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-to-mesenchymal transition (EMT) is a complex process involving multiple genes, steps and stages. It refers to the disruption of tight intercellular junctions among epithelial cells under specific conditions, resulting in loss of the original polarity, order and consistency of the cells. Following EMT, the cells show interstitial cell characteristics with the capacity for adhesion and migration, while apoptosis is inhibited. This process is critically involved in embryogenesis, wound-healing, tumor invasion and metastasis. The tumor microenvironment is composed of infiltrating inflammatory cells, stromal cells and the active medium secreted by interstitial cells. Most patients with hepatocellular carcinoma (HCC) have a history of hepatitis virus infection. In such cases, major components of the tumor microenvironment include inflammatory cells, inflammatory factors and virus-encoded protein are major components. Here, we review the relationship between EMT and the inflammatory tumor microenvironment in the context of HCC. We also further elaborate the significant influence of infiltrating inflammatory cells and inflammatory mediators as well as the products expressed by the infecting virus in the tumor microenvironment on the EMT process.

Citing Articles

Autophagy modulates physiologic and adaptive response in the liver.

Le T, Truong N, Holterman A Liver Res. 2025; 7(4):304-320.

PMID: 39958781 PMC: 11792069. DOI: 10.1016/j.livres.2023.12.001.


Ribosomal proteins in hepatocellular carcinoma: mysterious but promising.

Su Q, Sun H, Mei L, Yan Y, Ji H, Chang L Cell Biosci. 2024; 14(1):133.

PMID: 39487553 PMC: 11529329. DOI: 10.1186/s13578-024-01316-3.


EFNA5 suppresses cell proliferation and tumor metastasis in hepatoma via epithelial-to-mesenchymal transition.

Zhu Z, Hu S, Zhong X, Zhang Y, Wu X, Lin J Discov Oncol. 2024; 15(1):572.

PMID: 39424684 PMC: 11489415. DOI: 10.1007/s12672-024-01454-7.


Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy.

Helal I, Kamal M, Abd El-Aziz M, El Tayebi H Expert Rev Mol Med. 2024; 26:e18.

PMID: 39320855 PMC: 11440614. DOI: 10.1017/erm.2024.9.


Anti-liver tumor ingredient exploration and validation of Elephantopus tomentosus Linn. by combining in silico and in vitro experiments.

Zeng Z, Jia C, Li L, Jia D, Tang R, Li Y Sci Rep. 2024; 14(1):21086.

PMID: 39256453 PMC: 11387400. DOI: 10.1038/s41598-024-71629-3.


References
1.
Ai J, Zheng S, Zhang L, Jiang P, Dong J . [Vascular endothelial growth factor receptor-1 activation induces epithelial to mesenchmal transition in hepatocellular carcinoma cell line MHCC97-H.]. Zhonghua Gan Zang Bing Za Zhi. 2009; 17(2):112-6. View

2.
Kim J, Bae J . Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment. Mediators Inflamm. 2016; 2016:6058147. PMC: 4757693. DOI: 10.1155/2016/6058147. View

3.
Wang T, Jin Y, Zhao R, Wu Y, Zhang Y, Wu D . High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial-mesenchymal transition. Int J Infect Dis. 2014; 20:37-41. DOI: 10.1016/j.ijid.2013.11.015. View

4.
Liu H, Xu L, He H, Zhu Y, Liu J, Wang S . Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein. Cancer Sci. 2012; 103(12):2072-81. PMC: 7659259. DOI: 10.1111/cas.12017. View

5.
Fernando R, Castillo M, Litzinger M, Hamilton D, Palena C . IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011; 71(15):5296-306. PMC: 3148346. DOI: 10.1158/0008-5472.CAN-11-0156. View